Cargando…

Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study

PURPOSE: Gender differences in the incidence, susceptibility and severity of many obstructive airway diseases (OADs) have been well recognized. However, gender differences in the inhaled pharmacotherapy profile are not well characterized. METHODS: We conducted a retrospective cohort study to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amegadzie, Joseph Emil, Gamble, John-Michael, Farrell, Jamie, Gao, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533228/ https://www.ncbi.nlm.nih.gov/pubmed/33061353 http://dx.doi.org/10.2147/COPD.S264580

Ejemplares similares

Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study
por: Amegadzie, Joseph Emil, et al.
Publicado: (2022)

Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
por: Amegadzie, Joseph Emil, et al.
Publicado: (2022)

R(h)oads to microvesicles
por: Antonyak, Marc A., et al.
Publicado: (2012)

Where do conventional OADs stand
por: Sahay, Rakesh Kumar, et al.
Publicado: (2012)

Validated methods to identify patients with asthma–COPD overlap in healthcare databases: a systematic review protocol
por: Amegadzie, Joseph Emil, et al.
Publicado: (2019)

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)
por: Desouza, Cyrus, et al.
Publicado: (2020)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
por: Irusen, Elvis M., et al.
Publicado: (2020)

Inhaled Pharmacotherapy for Neonates: A Narrative Review
por: Rocha, Gustavo
Publicado: (2022)

Outcomes and Treatment Patterns of Adding a Third Agent to 2 OADs in Patients with Type 2 Diabetes
por: Levin, Philip A., et al.
Publicado: (2014)

The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease
por: Heraganahally, Subash S, et al.
Publicado: (2021)

Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
por: Shrashimirova, Milena, et al.
Publicado: (2023)

Evaluation of pharmacotherapy of obstructive airway diseases in the Montenegrin outpatient care: comparison with two Scandinavian countries
por: Duborija-Kovacevic, Natasha, et al.
Publicado: (2012)

Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach
por: Lin, Hui-Wen, et al.
Publicado: (2015)

Fabrication and Characteristics of ZnO/OAD-InN/PbPc Hybrid Solar Cells Prepared by Oblique-Angle Deposition
por: Chen, Cheng-Chiang, et al.
Publicado: (2012)

Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction
por: Arroyo, M.G., et al.
Publicado: (2016)

Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin
por: Blonde, Lawrence, et al.
Publicado: (2018)

A Novel Long Noncoding RNA, Lnc-OAD, Is Required for Bone Morphogenetic Protein 2- (BMP-2-) Induced Osteoblast Differentiation
por: Wang, Zonggui, et al.
Publicado: (2021)

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
por: Xu, You, et al.
Publicado: (2021)

Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review
por: Kalibala, Jacklean, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach
por: Lin, Hui-Wen, et al.
Publicado: (2018)

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH
por: Hwang, Anne, et al.
Publicado: (2018)

Correcting inhaler technique decreases severity of obstruction and improves quality of life among patients with obstructive airway disease
por: Khurana, Alkesh Kumar, et al.
Publicado: (2019)

Dry Powder and Budesonide Inhalation Suspension Deposition Rates in Asthmatic Airway-Obstruction Regions
por: Murayama, Norihide, et al.
Publicado: (2019)

Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2016)

Successful outcomes using Long Acting Buprenorphine (LAB - Buvidal) to treat Codeine, Tramadol and other Opioid Analgesia Dependencies (OAD) in Wales during the Pandemic
por: Melichar, J., et al.
Publicado: (2022)

Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future
por: Han, Yaopin, et al.
Publicado: (2022)

Erratum to: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2017)

Elongated uvula and diagnostic utility of spirometry in upper airway obstruction
por: Paliwal, Rajiv, et al.
Publicado: (2010)

The Role of Animal Models in Developing Pharmacotherapy for Obstructive Sleep Apnea
por: Kim, Lenise Jihe, et al.
Publicado: (2019)

Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease
por: Lamas, Adelaida, et al.
Publicado: (2016)

Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases
por: Kawamatawong, Theerasuk, et al.
Publicado: (2017)

Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review
por: Dhar, Raja, et al.
Publicado: (2022)

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
por: Kaul, Subuhi, et al.
Publicado: (2020)

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
por: Amegadzie, Joseph E., et al.
Publicado: (2023)

Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines
por: Kankaanranta, Hannu, et al.
Publicado: (2015)

Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?
por: Fleury Curado, Thomaz, et al.
Publicado: (2019)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness
por: Mendonça, Nancy T, et al.
Publicado: (2011)

Airway Responsiveness to Inhaled Aspirin is Influenced by Airway Hyperresponsiveness in Asthmatic Patients
por: Kim, Sungsoo, et al.
Publicado: (2010)

Inhalation Exposure Analysis of Lung-Inhalable Particles in an Approximate Rat Central Airway
por: Dong, Jingliang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lenetfecl5gf4mu1qi96t3qng6